We focus exclusively on companies within the healthcare industry. We believe our expertise enables us to proactively identify attractive companies and subsectors of investment, move with speed and certainty in a transaction, and accelerate value creation post close.
Control positions in healthcare businesses
Partial recapitalizations or buyouts
Target platform EBITDA of $3 to $20 million
Target equity investments of $15 to $100 million (including add-ons)
Healthcare Providers
Healthcare Outsourced Services
Consumer Health & Products
Founder-owned, entrepreneurially led businesses
Strong business model, with a history of consistent growth and profitability
Attractive underlying secular growth trends and market fragmentation
Diversified client bases, with no/limited FDA approval risk or biopharmaceutical risk
Headquartered in the United States or Canada